EDAR anticorps (AA 31-245)
Aperçu rapide pour EDAR anticorps (AA 31-245) (ABIN2620237)
Antigène
Voir toutes EDAR AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 31-245
-
Specificité
- Human ED3 / EDAR.
-
Purification
- Immunoaffinity purified
-
Immunogène
-
Recombinant fragment corresponding to a region within amino acids 31 and 245 of EDAR (SwissProt Q9UNE0). Percent identity by BLAST analysis: Human (100%).
Type of Immunogen: Recombinant protein -
Isotype
- IgG
-
-
-
-
Indications d'application
- Approved: IHC, IHC-P (1:100 - 1:1000)
-
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, pH 7, 1 % BSA, 20 % Glycerol, 0.01 % Thimerosal
-
Agent conservateur
- Thimerosal (Merthiolate)
-
Précaution d'utilisation
- This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Conseil sur la manipulation
- Avoid multiple freeze-thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- Keep as concentrated solution. Aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- EDAR (Ectodysplasin A Receptor (EDAR))
-
Autre désignation
- EDAR
-
Sujet
-
Name/Gene ID: EDAR
Synonyms: EDAR, Ectodysplasin-A receptor, ED1R, EDA-A1 receptor, EDA1R, DL, Downless, mouse, homolog of, ED3, EDA3, ECTD10A, ECTD10B, Ectodysplasin A receptor, ED5, Downless homolog, Ectodermal dysplasia receptor, EDA-A1R, HRM1 -
ID gène
- 10913
-
Pathways
- Tube Formation, Ubiquitin Proteasome Pathway
Antigène
-